Source: International Congress 2019 – Tuberculosis: from diagnosis to complications
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Handayani (Jakarta, Indonesia), I. Fajarwati (Jakarta, Indonesia), G. Priyonugroho (Jakarta, Indonesia), E. Burhan (Jakarta, Indonesia), T. Kusmiati (Surabaya, Indonesia), I. Muzakkir (Makassar, Indonesia), P. Siagian (Medan, Indonesia), B. Riyanto (Yogyakarta, Indonesia), B. Wibisono (Semarang, Indonesia), I. Sajinadiyasa (Bali, Indonesia), N. Susanto (Jakarta, Indonesia). Radiologic pattern as a predictor of multi-drug resistant tuberculosis; a multicenter study.. 2956

Member's Comments

No comment yet.

Related content which might interest you: A multicentric cohort analysis of culture conversion and reversion in multidrug resistant tuberculosis (MDRTB) patients Source: Annual Congress 2013 –Drug-resistant tuberculosis: new clinical and public health insights Year: 2013 Multi-drug resistant tuberculosis: a retrospective analysis of cases over 10 years in a low incidence setting Source: Annual Congress 2007 - Multidrug-resistant tuberculosis and the emerging threat of extensively drug-resistant tuberculosis Year: 2007 Clofazimine for the treatment of multidrug-resistant tuberculosis: Prospective, multicenter, randomized controlled study in China Source: International Congress 2015 – TB treatment: new drugs and drug resistance Year: 2015 Bedaquiline and delamanid for the treatment of multidrug-resistant tuberculosis: a multicentre cohort study in Korea Source: Eur Respir J, 51 (3) 1702467; 10.1183/13993003.02467-2017 Year: 2018 Prospective study of mycobacterium tuberculosis drug resistance in Tunisia Source: Eur Respir J 2004; 24: Suppl. 48, 658s Year: 2004 The treatment outcomes of isoniazid resistant tuberculosis: Multicenter and retrospective study in South Korea Source: Annual Congress 2010 - Emerging drug resistance in tuberculosis Year: 2010 Bedaquiline containing regimens for the treatment of multi- and extensively drug-resistant tuberculosis at the programmatic level in Belarus. Prospective cohort study. Source: International Congress 2019 – Drug-resistant tuberculosis Year: 2019 Multicentre randomised clinic study of new standard chemotherapy regimen for new cases patients of pulmonary tuberculosis executed in Russia regions with high level of multiple drug resistance (MDR) Source: Annual Congress 2009 - Tuberculosis control Year: 2009 Outcome of pulmonary multidrug-resistant tuberculosis: a 6-yr follow-up study Source: Eur Respir J 2006; 28: 980-985 Year: 2006 The clinical and radiological comparison of new, recurrent and multidrug resistant cases of pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 169s Year: 2002 Drug resistance pattern & response to supervised chemotherapy of drug resistant pulmonary tuberculosis - a study of hospitalized cases from tuberculosis diseases treatment centre Source: Eur Respir J 2003; 22: Suppl. 45, 524s Year: 2003 Treatment outcome of multi-drug resistant tuberculosis Source: Annual Congress 2004 - Problems of resistance and HIV coinfection in tuberculosis Year: 2004 A 10-year prospective surveillance of Mycobacterium tuberculosis drug resistance in France 1995 2004 Source: Eur Respir J 2007; 30: 937-944 Year: 2007 Time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis: a prospective cohort study from urban China Source: Eur Respir J , 49 (3) 1601558; DOI: 10.1183/13993003.01558-2016 Year: 2017 A two-year post-treatment follow-up of multi-drug resistant tuberculosis cases who completed a programmatic MDR-TB management at the lung center of the Philippines – a preliminary report Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis Year: 2009 LATE-BREAKING ABSTRACT: Clofazimine for the treatment of multidrug-resistant tuberculosis: Multicenter, randomized controlled study Source: Annual Congress 2013 –Tuberculosis: epidemiology and public health management II Year: 2013 A study of role of rifabutin as an adjuvant in management of cases with multi-drug resistant pulmonary tuberculosis Source: Annual Congress 2007 - Medical and surgical treatment of susceptible and resistant tuberculosis Year: 2007 Clinical efficacy of sitafloxacin for refractory non-tuberculous mycobacterial lung disease: A single-center retrospective study Source: International Congress 2019 – Clinical investigations of non-TB mycobacterial infection Year: 2019 Linezolid tolerability in multidrug-resistant tuberculosis: a retrospective study Source: Eur Respir J 2015; 46: 1205-1207 Year: 2015 Prospective study of nosocomial spread of tuberculosis Source: Annual Congress 2012 - Tuberculous and non-tuberculous mycobacterial infections: epidemiology I Year: 2012